Clinical Trial: A Study to Test Asundexian to Prevent a Clot-related Stroke in Participants After an Acute Ischemic Stroke or High-risk TIA/Mini-stroke (Transient Ischemic Attack)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Prevention of Ischemic Stroke
Study Type: INTERVENTIONAL
Official Title: A Multicenter, International, Randomized, Placebo Controlled, Double-blind, Parallel Group and Event Driven Phase 3 Study of the Oral FXIa Inhibitor Asundexian (BAY 2433334) for the Prevention of Isch
Brief Summary:
Researchers are looking for a better way to prevent an ischemic stroke which occurs when a blood clot travelled to the brain in people who within the last 72 hours had:an acute stroke due to a blood clot that formed outside the heart (acute non-cardioembolic ischemic stroke), orTIA/mini-stroke with a high risk of turning into a stroke (high-risk transient ischemic attack), and who are planned to receive standard of care therapy.Acute ischemic strokes or TIA/mini-stroke result from a blocked or reduced…
Read more